Proteasome inhibitors: antitumor effects and beyond.

Yun Dai, Mohamed Rahmani, Steven Grant, Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process Oncogene. ,vol. 22, pp. 7108- 7122 ,(2003) , 10.1038/SJ.ONC.1206863

Julian Adams, The development of proteasome inhibitors as anticancer drugs. Cancer Cell. ,vol. 5, pp. 417- 421 ,(2004) , 10.1016/S1535-6108(04)00120-5

Giorgio Scagliotti, Proteasome inhibitors in lung cancer. Critical Reviews in Oncology Hematology. ,vol. 58, pp. 177- 189 ,(2006) , 10.1016/J.CRITREVONC.2005.12.001

Dharminder Chauhan, Laurence Catley, Guilan Li, Klaus Podar, Teru Hideshima, Mugdha Velankar, Constantine Mitsiades, Nicolas Mitsiades, Hiroshi Yasui, Anthony Letai, Huib Ovaa, Celia Berkers, Benjamin Nicholson, Ta-Hsiang Chao, Saskia T.C. Neuteboom, Paul Richardson, Michael A. Palladino, Kenneth C. Anderson, A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib Cancer Cell. ,vol. 8, pp. 407- 419 ,(2005) , 10.1016/J.CCR.2005.10.013

Christine Wong, Michael Morse, Smita K. Nair, Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides Journal of Immunotherapy. ,vol. 21, pp. 32- 40 ,(1998) , 10.1097/00002371-199801000-00004

Susana Salceda, Jaime Caro, Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions Journal of Biological Chemistry. ,vol. 272, pp. 22642- 22647 ,(1997) , 10.1074/JBC.272.36.22642

Binhua P. Zhou, Jiong Deng, Weiya Xia, Jihong Xu, Yan M. Li, Mehmet Gunduz, Mien-Chie Hung, Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition Nature Cell Biology. ,vol. 6, pp. 931- 940 ,(2004) , 10.1038/NCB1173

Jiangping Wu, On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants. American Journal of Transplantation. ,vol. 2, pp. 904- 912 ,(2002) , 10.1034/J.1600-6143.2002.21006.X

Angelo Michele Carella, Emanuela Merla, Angelo Michele Carella, Mario Boccadoro, Nicola Cascavilla, Antonio Palumbo, Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Tommasina Guglielmelli, Renato Zambello, Enrico Balleari, Lucio Catalano, Mauro Spriano, Federica Cavallo, Antonio La Sala, Saverio Mantuano, Michele Nobile, Lorella Melillo, Potito Rosario Scalzulli, Matteo Dell’Olio, Carlo Bodenizza, Michele Mario Greco, Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide Leukemia Research. ,vol. 30, pp. 283- 285 ,(2006) , 10.1016/J.LEUKRES.2005.06.027

William G. Kaelin, The Concept of Synthetic Lethality in the Context of Anticancer Therapy Nature Reviews Cancer. ,vol. 5, pp. 689- 698 ,(2005) , 10.1038/NRC1691